DDrare: Database of Drug Development for Rare Diseases

Procedure: dexa, blood tests, h.g.p.o, osseous age. (DrugBank: -)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
78	下垂体前葉機能低下症	1
193	プラダー・ウィリ症候群	1

78. 下垂体前葉機能低下症　［臨床試験数：462，薬物数：346（DrugBank：45），標的遺伝子数：41，標的パスウェイ数：80］

Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 462 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01298180 (ClinicalTrials.gov)	January 2009	6/11/2009	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Prader-Willi Syndrome;Growth Hormone Deficiency	Drug: Growth hormone (Genotonorm® or Omnitrope®);Procedure: DEXA, blood tests, H.G.P.O, osseous age.;Procedure: biopsy	University Hospital, Toulouse	NULL	Completed	1 Year	5 Years	Both	111	Phase 4	France

193. プラダー・ウィリ症候群　［臨床試験数：95，薬物数：104（DrugBank：27），標的遺伝子数：50，標的パスウェイ数：63］

Searched query = "Prader-Willi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 95 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01298180 (ClinicalTrials.gov)	January 2009	6/11/2009	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?	Prader-Willi Syndrome;Growth Hormone Deficiency	Drug: Growth hormone (Genotonorm® or Omnitrope®);Procedure: DEXA, blood tests, H.G.P.O, osseous age.;Procedure: biopsy	University Hospital, Toulouse	NULL	Completed	1 Year	5 Years	Both	111	Phase 4	France